Evidence map›Paper›PMID 32680548›Full record

Trial reportTrials2020

Whey protein supplementation reducing fasting levels of anandamide and 2-AG without weight loss in pre-menopausal women with obesity on a weight-loss diet.

Fatemeh Haidari, Vahideh Aghamohammadi, Majid Mohammadshahi, Kambiz Ahmadi-Angali, Mohammad Asghari-Jafarabadi

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 5 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 5 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Fatemeh HaidariDepartment of Nutrition, Nutrition and Metabolic Research Center, Faculty of Paramedical Sciences, Ahvaz Jundishapur University of Medical Sciences, Golestan Street, Ahvaz, Iran.
Vahideh AghamohammadiDepartment of Nutrition, Nutrition and Metabolic Research Center, Faculty of Paramedical Sciences, Ahvaz Jundishapur University of Medical Sciences, Golestan Street, Ahvaz, Iran. v_agamohammadi@yahoo.com.
Majid MohammadshahiDepartment of Nutrition, Nutrition and Metabolic Research Center, Faculty of Paramedical Sciences, Ahvaz Jundishapur University of Medical Sciences, Golestan Street, Ahvaz, Iran.
Kambiz Ahmadi-AngaliDepartment of Statistics and Epidemiology, Faculty of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Mohammad Asghari-JafarabadiDepartment of Statistics and Epidemiology, Faculty of Health, Tabriz University of Medical Sciences, Tabriz, Iran.
Ahvaz Jundishapur University of Medical Sciences · IRTabriz University of Medical Sciences · IR

Funding

Ahvaz Jundishapur University of Medical Sciences NRC-9513
6 · The paper itself

Abstract

backgroundDespite the importance of dairy proteins in modifying of metabolic abnormalities, no attention has been given to their effects on endocannabinoids.

methodsA total number of 60 obese women were recruited in a 2-month randomized clinical trial. Following random allocation, they were assigned to one of the two groups: control (n = 30) and intervention (n = 30). Then, all the subjects followed a hypocaloric diet of 800 kcal below estimated energy needs. The intervention group received isocaloric weight-loss diet and whey protein powders (30 g/day). Baseline and 2-month fasting anthropometric, blood glucose, serum insulin, insulin resistance, lipid profile, AEA, and 2-AG were measured.

resultsThe study groups were homogenous in terms of baseline characteristics (p > 0.05) except for MUFA intake (p = 0.021). There were no significant differences in energy and macronutrient intakes in the intervention group compared to the control group at the end of the study (p > 0.05). The results of the ANCOVA did not show significant reductions in body weight and BMI of the intervention group compared to the control group (p > 0.05); however, WC, body fat, FBS, AEA, 2-AG, total cholesterol, and triglyceride decreased and HDL-c significantly increased in the intervention group compared to the control group (p < 0.05).

conclusionsIn this study, the effects of simultaneous weight-loss diet and whey protein supplementation on the reduction of endocannabinoids were determined.

trial registrationIranian Registry of Clinical Trials IRCT2017021410181N8 . Registered on March 2017.

Indexed as

Dietary SupplementsDiet, ReducingWeight LossAdultArachidonic AcidsBlood GlucoseBody Mass IndexEndocannabinoidsFastingFemaleHumansInsulinIranLipidsObesityPolyunsaturated AlkamidesanandamideArachidonic AcidsBlood GlucoseEndocannabinoidsInsulinLipidsPolyunsaturated AlkamidesWhey ProteinsEndocannabinoidsHypocaloric dietObesityWeight lossWhey protein

Identifiers

PMID32680548
PMCPMC7366891
OpenAlexW3043688540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.